USCWA
ASXC

U.S. Capital Wealth Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,500
Closed -$3.3K – 1581
2022
Q4 		$3.3K Buy
+9,500
New +$3.86K ﹤0.01% 1443

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

U.S. Capital Wealth Advisors's ASXC Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2023, closing a stake of 9,500 shares — an estimated $3.3K sold.

U.S. Capital Wealth Advisors first reported a position in ASXC in Q4 2022 and held it in 1 quarter. The position peaked at $3.3K in Q4 2022. 79 funds tracked by Wall St. Rank hold ASXC as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 9,500 Asensus Surgical, Inc. shares in Q1 2023, an estimated $3.3K.
  • U.S. Capital Wealth Advisors first reported a position in Asensus Surgical, Inc. in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Asensus Surgical, Inc. position peaked at $3.3K in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.